Migraine Clinical Trials in Tampa, Florida

5 studies are recruiting for migraine in Tampa, Florida right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)

    Migraine is a common neurological disorder typically characterized by attacks of throbbing, moderate to severe headache, often associated with nausea, vomiting, and sensitivity to light and sound. Migraine is extremely common and disabling in children. The purpose of this study is to evaluate how s…

    Stage
    Phase 3
    Ages
    6 to 17
    Site
    University of South Florida- Neuroscience Institute /ID# 229324, Tampa, Florida
    Locations
    129 in total
    Run by
    AbbVie

    See if you can join NCT05125302 on ClinicalTrials.gov

  2. Study of EVO756 in Adults With Migraine

    This study will evaluate the efficacy and safety of EVO756 against placebo in adults with migraine.

    Stage
    Phase 2
    Ages
    18 to 64
    Site
    Vantage Clinical Trials, Tampa, Florida
    Locations
    26 in total
    Run by
    Evommune, Inc.

    See if you can join NCT07616128 on ClinicalTrials.gov

  3. Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects

    The purpose of this study is to compare the efficacy and safety of rimegepant to placebo as a preventative treatment for migraine in children and adolescents ≥ 6 to <18 years with episodic migraine.

    Stage
    Phase 3
    Ages
    6 to 17
    Site
    Santos Research Center, CORP, Tampa, Florida
    Locations
    93 in total
    Run by
    Pfizer

    See if you can join NCT05156398 on ClinicalTrials.gov

  4. A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine

    The main goal of the study is to assess the long-term safety of eptinezumab on children and adolescents ages 6 to 17 with chronic or episodic migraine.

    Stage
    Phase 3
    Ages
    6 to 17
    Site
    University of South Florida, Tampa, Florida
    Locations
    70 in total
    Run by
    H. Lundbeck A/S

    See if you can join NCT05164172 on ClinicalTrials.gov

  5. A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migraine

    The purpose of this Phase 2 study is to evaluate the safety and efficacy of SC MEDI0618 compared to placebo in participants with episodic migraine.

    Stage
    Phase 2
    Ages
    18 to 70
    Site
    Santos Research Center, Corp - Tampa, Tampa, Florida
    Locations
    54 in total
    Run by
    AbbVie

    See if you can join NCT06602479 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.